Sign in to continue:

Friday, March 20th, 2026

Ultragreen: Global ICG Market Leader Driving 23% Earnings CAGR & High Margins Through Surgical Innovation 1

Broker Name: DBS

Date of Report: 2024

Excerpt from DBS report.

Report Summary

  • Ultragreen is the global leader in indocyanine green (ICG) with over 60% market share, benefitting from high entry barriers and strong regulatory protection.
  • The ICG market is expected to grow rapidly, at an 11.7% CAGR from 2024-2030, driven by increasing adoption of fluorescence guided surgery and international expansion.
  • Ultragreen is forecasted to deliver a 23% earnings CAGR from FY24-27, with growth supported by rising ICG penetration, robust margins, and new regulatory approvals.
  • DBS initiates coverage with a BUY rating and a target price of USD2.05, valuing the company at a premium based on solid growth prospects and defensible market position.

Above is an excerpt from a report by DBS. Clients of DBS can be the first to access the full report from the DBS website: https://www.dbs.com

Maximizing Returns on Surging Gold Prices at Minimal Expense

Maximizing Returns on Surging Gold Prices at Minimal Expense...

Thai Beverage (THBEV) Stock Analysis 2025: Growth Outlook, Financials, and IPO Upside Potential

Broker: Maybank Kim Eng Research Date of Report: July 21, 20...

   Ad